| P50 | author | Ming-Hua Zheng | Q37831296 |
| | Gui-qi Zhu | Q42757517 |
| | Keqing Shi | Q59704601 |
| P2093 | author name string | Yong-Ping Chen | |
| | Jie You | |
| | Martin Braddock | |
| | Li-Ren Wang | |
| | Sun-Yue He | |
| P2860 | cites work | Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver | Q24244065 |
| | Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis | Q24606203 |
| | Global cancer statistics, 2002 | Q27860562 |
| | Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer | Q27860681 |
| | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860749 |
| | Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial | Q28036747 |
| | FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study | Q28189472 |
| | Evaluating non-randomised intervention studies | Q29619272 |
| | Combination of direct and indirect evidence in mixed treatment comparisons | Q29619499 |
| | The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials | Q29619501 |
| | Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents | Q31111685 |
| | Arterial, portal, or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma | Q33704676 |
| | Surgical therapy of hepatic colorectal metastasis | Q33755624 |
| | Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. | Q33865150 |
| | Hepatic colorectal metastasis: current surgical therapy, selection criteria for hepatectomy, and role for adjuvant therapy. | Q34039162 |
| | Simultaneous comparison of multiple treatments: combining direct and indirect evidence. | Q34081552 |
| | Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer | Q34506398 |
| | Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group | Q34511070 |
| | Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study | Q34521660 |
| | Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials | Q34597234 |
| | Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52 | Q35643367 |
| | Bayesian methods for evidence synthesis in cost-effectiveness analysis | Q36381197 |
| | Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer | Q36822186 |
| | Use of indirect and mixed treatment comparisons for technology assessment | Q37259556 |
| | Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy | Q37287048 |
| | Checking consistency in mixed treatment comparison meta-analysis | Q37705195 |
| | Role of adjuvant therapy after resection of colorectal cancer liver metastases | Q37724550 |
| | Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and meta-analysis of randomized controlled trials | Q37996818 |
| | Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen) | Q43672614 |
| | Hepatic arterial infusion after liver resection | Q45270082 |
| | A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. | Q45945682 |
| | A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver | Q47575070 |
| | Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. | Q53187956 |
| | Liver resection for colorectal metastases | Q73132137 |
| | Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study | Q73595099 |
| | Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases | Q78099360 |
| | Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial | Q79317414 |
| P275 | copyright license | Creative Commons Attribution-NoDerivs 4.0 International | Q36795408 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| | antineoplastic | Q2853144 |
| | liver neoplasm | Q18558073 |
| | local neoplasm recurrence | Q54945651 |
| | colorectal neoplasm | Q58833976 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e379 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | Systematic review with network meta-analysis: adjuvant chemotherapy for resected colorectal liver metastases | |
| P478 | volume | 94 | |